The US-developed COVID-19 vaccine was rubber-stamped by the European Commission after getting conditional market approval from the EU’s medical watchdog.
The European Medicines Agency (EMA) recommended Moderna’s COVID-19 vaccine for conditional market authorization on Wednesday, the agency announced following a meeting.
It is the second vaccine authorised for use in the 27-nation bloc.
